☰

Kathleen Maguire-Zeiss - Publications

Affiliations: 
Neuroscience Georgetown University, Washington, DC 
Area:
Neuroscience Biology
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Winland CD, Welsh N, Sepulveda-Rodriguez A, Vicini S, Maguire-Zeiss KA. Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons. The European Journal of Neuroscience. PMID 28921719 DOI: 10.1111/ejn.13711  0.4
2013 Huang L, Shimoji M, Wang J, Shah S, Kamila S, Biehl ER, Lim S, Chang A, Maguire-Zeiss KA, Su X, Federoff HJ. Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 840-51. PMID 23963789 DOI: 10.1007/s13311-013-0208-3  0.4
2013 Béraud D, Hathaway HA, Trecki J, Chasovskikh S, Johnson DA, Johnson JA, Federoff HJ, Shimoji M, Mhyre TR, Maguire-Zeiss KA. Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 94-117. PMID 23054368 DOI: 10.1007/s11481-012-9401-0  0.4
2011 Feng LR, Maguire-Zeiss KA. Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance. Neurotoxicity Research. 20: 387-401. PMID 21735318 DOI: 10.1007/s12640-011-9255-x  0.92
2010 Khandelwal PJ, Dumanis SB, Feng LR, Maguire-Zeiss K, Rebeck G, Lashuel HA, Moussa CE. Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model. Molecular Neurodegeneration. 5: 47. PMID 21050448 DOI: 10.1186/1750-1326-5-47  0.92
2010 Lee BD, Shin JH, VanKampen J, Petrucelli L, West AB, Ko HS, Lee YI, Maguire-Zeiss KA, Bowers WJ, Federoff HJ, Dawson VL, Dawson TM. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nature Medicine. 16: 998-1000. PMID 20729864 DOI: 10.1038/nm.2199  0.4
2010 Feng LR, Federoff HJ, Vicini S, Maguire-Zeiss KA. Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability. The European Journal of Neuroscience. 32: 10-7. PMID 20550572 DOI: 10.1111/j.1460-9568.2010.07266.x  0.92
2010 Maguire-Zeiss KA, Federoff HJ. Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 1019-25. PMID 20549523 DOI: 10.1007/s00702-010-0431-6  0.4
2010 Feng LR, Maguire-Zeiss KA. Gene therapy in Parkinson's disease: rationale and current status. Cns Drugs. 24: 177-92. PMID 20155994 DOI: 10.2165/11533740-000000000-00000  0.92
2009 Su X, Federoff HJ, Maguire-Zeiss KA. Mutant alpha-synuclein overexpression mediates early proinflammatory activity. Neurotoxicity Research. 16: 238-54. PMID 19526281 DOI: 10.1007/s12640-009-9053-x  0.4
2009 Maguire-Zeiss KA, Federoff HJ. Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 4: 298-308. PMID 18931916 DOI: 10.1007/s11481-008-9133-3  0.4
2008 Johnston LC, Su X, Maguire-Zeiss K, Horovitz K, Ankoudinova I, Guschin D, Hadaczek P, Federoff HJ, Bankiewicz K, Forsayeth J. Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1392-9. PMID 18545225 DOI: 10.1038/mt.2008.113  0.4
2008 Maguire-Zeiss KA, Mhyre TR, Federoff HJ. Gazing into the future: Parkinson's disease gene therapeutics to modify natural history. Experimental Neurology. 209: 101-13. PMID 18035353 DOI: 10.1016/j.expneurol.2007.09.030  0.4
2008 Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ. Synuclein activates microglia in a model of Parkinson's disease. Neurobiology of Aging. 29: 1690-701. PMID 17537546 DOI: 10.1016/j.neurobiolaging.2007.04.006  0.4
2008 Mhyre TR, Loy R, Tariot PN, Profenno LA, Maguire-Zeiss KA, Zhang D, Coleman PD, Federoff HJ. Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium. Neurobiology of Aging. 29: 1631-43. PMID 17521776 DOI: 10.1016/j.neurobiolaging.2007.04.004  0.4
2007 Sortwell CE, Bowers WJ, Counts SE, Pitzer MR, Fleming MF, McGuire SO, Maguire-Zeiss KA, Federoff HJ, Collier TJ. Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival. Brain Research. 1134: 33-44. PMID 17196186 DOI: 10.1016/j.brainres.2006.11.079  0.4
2006 Maguire-Zeiss KA, Wang CI, Yehling E, Sullivan MA, Short DW, Su X, Gouzer G, Henricksen LA, Wuertzer CA, Federoff HJ. Identification of human alpha-synuclein specific single chain antibodies. Biochemical and Biophysical Research Communications. 349: 1198-205. PMID 16973126 DOI: 10.1016/j.bbrc.2006.08.127  0.4
2006 Bowers WJ, Mastrangelo MA, Howard DF, Southerland HA, Maguire-Zeiss KA, Federoff HJ. Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 580-8. PMID 16412694 DOI: 10.1016/j.ymthe.2005.11.011  0.4
2005 Maguire-Zeiss KA, Short DW, Federoff HJ. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Brain Research. Molecular Brain Research. 134: 18-23. PMID 15790526 DOI: 10.1016/j.molbrainres.2004.09.014  0.4
2004 Maguire-Zeiss KA, Federoff HJ. Safety of viral vectors for neurological gene therapies. Current Opinion in Molecular Therapeutics. 6: 473-81. PMID 15537048  0.4
2003 Maguire-Zeiss KA, Federoff HJ. Convergent pathobiologic model of Parkinson's disease. Annals of the New York Academy of Sciences. 991: 152-66. PMID 12846984  0.4
2002 Maguire-Zeiss KA, Bowers WJ, Federoff HJ. Somatic mosaic approaches and the aging brain. Neurobiology of Aging. 23: 977-84. PMID 12392799 DOI: 10.1016/S0197-4580(02)00077-5  0.4
Show low-probability matches.